The BCLC group was created in 1986. We are a multidisciplinary group dedicated to the management and research in liver cancer.
Joined December 2015
- Tweets 1,820
- Following 266
- Followers 4,658
- Likes 1,495
882 Photos and videos
Pinned Tweet
Feb 8
Final print of BCLC 2025 available at authors.elsevier.com/c/1mZTW… A team effort by BCLC members and external experts. Incorporation of CUSE concepts into the MTBoard allows personalised recommendations @hospitalclinic @idibaps @EASLnews @ILCAnews @AEEHLiver @ContraCancerEs
74
148
13,158
Jun 11
Today Carla Fuster MD obtained her PhD after a brilliant exposure of pathology profiling of liver cancer. Great work mentored by @ma5RN & Prof Alba Diaz. A promising career ahead. Colleagues and family are proud and happy!! @hospitalclinic @idibaps @APClinicBCN
1
2
17
1,929
Jun 9
Our BCLC senior radiologist Prof Carmen Ayuso was awarded today the Honorary Fellowship by @EsgarSociety Big recognition to a fruitful career. @hospitalclinic @idibaps @ContraCancerEs @SERAM_RX @myESR @RXabdominalHCB
4
20
778
May 29
#easl2026 session devoted to AI and liver cancer. Great interaction with @nllarch and @MaarioMatute from the BCLC leading the action. A reflection of how multiples disciplines conform our activity @hospitalclinic @idibaps @ContraCancerEs @AEEHLiver @EASLnews
1
8
331
May 17
Major international IPD effort by @ma5RN @AndrewMMoon and @tedradonc crafting a great team to assess the survival of almost 5000 HCC patients treated with EBRT and stratified by BCLC stage. Best information available to consider EBRT in clinical practice
pubmed.ncbi.nlm.nih.gov/4213…
15
19
6,366
BCLC GROUP retweeted
Decidir en la incertidumbre del cáncer de hígado – Salud y Medicina saludymedicina.org/post/deci…
2
2
333
May 6
The Nurse expertise and knowledge as central players in the BCLC strategy for conventional care and research. pubmed.ncbi.nlm.nih.gov/4176… The strength of a team relies on all its members @gemmaiserte @nllarch @AndrewMMoon @ma5RN in @SeminLiverDis
6
14
1,138
Apr 25
The BCLC 2026 update program is defined. Bringing experts from all continents to prime international exchange of concepts across regions. Interaction secured to allow fruitful debates. Not to miss on site or remote inscripcions.academia.cat/fo…
27
73
5,539
Mar 16
The BCLC update 2027 takes place next November 16-17. Again, interactive format to debate around hot topics in liver cancer and how to optimally manage patients diagnosed with it. Expert international faculty secures scientific strength.
Registration inscripcions.academia.cat/fo…
5
22
1,972
Feb 24
Results of the GOING investigator initiated trial for 2nd line in HCC are already on-line. We tested a sequential add-on strategy rather than two drugs from star. Encouraging response rate while preserving safety. pubmed.ncbi.nlm.nih.gov/4172…
@hospitalclinic @idibaps @ContraCancerEs
1
3
8
767
Today is the #WorldCCADay when we join @CCA_Alliance in raising awareness of cholangiocarcinoma (CCA).
Early symptoms are rare, making diagnosis difficult.
With surgery as the only curative option, early detection is critical to improving outcomes.
4
8
384
Feb 19
Colangiocarcinoma awareness at its best in Barcelona. Sagrada Familia in green!! @hospitalclinic @idibaps @atuvibi @ContraCancerEs @ILCAnews @EASLnews
Picture by our APNurse @gemmaiserte
4
23
752
🆕#CLÍNIC-#IDIBAPS participates in the new International Consensus on cholangiocarcinoma
This document provides a comprehensive update on the knowledge available about this aggressive liver tumour, whose incidence is rising worldwide
#WorldCCADay🟢
👉f.mtr.cool/luujtcedck
1
3
9
494
Feb 18
Great informative talk by @MarcoSanduzzi about future prospects of systemic treatment for HCC at the @AEEHLiver PGC. Experience knowledge @hospitalclinic @idibaps @ContraCancerEs
2
11
802
It’s official – #ILCA26 is returning to Europe!
Join us in Brussels, Belgium, on 3–5 September 2026 for three days of insights into the latest in #livercancer research.
@StephenLChan1 @docamitgs @Valeriechew29 @LorenzaRimassa @AnjanaPillaiMD @siadaniela @allaire_manon
3
8
2,137
22 Dec 2025
A BCLC systematic review/meta-analysis of OS of HCC patients with vasc invasion receiving treatment in @HEP_Journal Heterogeneity across cohorts prevents robust figures except with TARE that offers a a pooled 1-year OS of 34% (95%CI:2–48%) @hospitalclinic pubmed.ncbi.nlm.nih.gov/4139…
2
16
43
3,347
22 Dec 2025
Very informative @HEP_Journal review about imaging for response evaluation of systemic agents in HCC by @MaarioMatute @maximeronot @VChernyakMD Sangro & @JordiRimola. Not an easy task. Major expertise needed @hospitalclinic @AEEHLiver @SERAM_RX @ILCAnews
journals.lww.com/hep/fulltex…
9
23
1,614
10 Dec 2025
Was a nice meeting with major interaction to prime further collaborative efforts to improve liver cancer care and research. Looking forward to Berlin 2026!!
Two weeks after #ILCA25, the message is clear:
Personalized care smart tech will shape the future of liver cancer treatment.
Over 530 participants • 18 countries • 12 disciplines • 30 sessions. Collaboration makes it possible.
See you in Berlin for #ILCA26! 📸
4
768
26 Nov 2025
Our postdoc @martafortuny10 chairs the Symposium of Young Investigators in the 1st CIBERDEM-CIBEREHD Joint Conference. Step by step growth of a scientific career @SaludISCIII @idibaps
1
9
376
Vols saber més sobre el càncer de fetge?
🗓️Apuntat a les visites guiades de dijous 20 de novembre a les 10:00 i a les 12.00
👉f.mtr.cool/dqpposzxjg
1
1
2
400